See more : Cimmco Limited (CIMMCO.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Perimeter Medical Imaging AI, Inc. (PYNKF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Perimeter Medical Imaging AI, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Woodbois Limited (WBI.L) Income Statement Analysis – Financial Results
- Broad Capital Acquisition Corp (BRACR) Income Statement Analysis – Financial Results
- Sun Hung Kai Properties Limited (0016.HK) Income Statement Analysis – Financial Results
- Jindal Drilling & Industries Limited (JINDRILL.NS) Income Statement Analysis – Financial Results
- Taisun Int’l (Holding) Corporation (8480.TW) Income Statement Analysis – Financial Results
Perimeter Medical Imaging AI, Inc. (PYNKF)
About Perimeter Medical Imaging AI, Inc.
Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT, B-series OCT, and OCT imaging console. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. was founded in 2013 and is headquartered in Toronto, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 403.53K | 132.77K | 11.34K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 197.11K | 32.14K | 6.30K | 47.57K | 51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 206.42K | 100.63K | 5.04K | -47.57K | -51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 51.15% | 75.79% | 44.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 6.83M | 5.48M | 4.50M | 468.31K | 643.35K | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 6.12M | 5.45M | 7.89M | 8.84M | 7.51M | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 4.96M | 4.84M | 3.67M | 122.94K | 36.78K | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 14.68M | 10.28M | 11.56M | 8.96M | 7.54M | 135.62K | 123.44K | 137.17K | 184.42K |
Other Expenses | 0.00 | 463.68K | 3.57K | 629.17K | 376.57K | 20.42K | 0.00 | 0.00 | 0.00 |
Operating Expenses | 21.51M | 16.22M | 16.06M | 10.06M | 8.56M | 115.20K | 123.44K | 137.17K | 184.42K |
Cost & Expenses | 21.58M | 16.25M | 16.07M | 10.06M | 8.56M | 115.20K | 123.44K | 137.17K | 184.42K |
Interest Income | 0.00 | 0.00 | 10.36K | 6.90K | 4.65K | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 104.93K | 110.31K | 117.05K | 155.97K | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 614.70K | 1.04M | 93.84K | 47.57K | 51.84K | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -13.28M | -11.72M | -15.95M | -6.11M | -7.01M | -115.20K | -123.44K | -137.17K | -184.42K |
EBITDA Ratio | -3,290.15% | -11,539.44% | -140,655.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -20.73M | -16.12M | -16.05M | -11.67M | -13.02M | -115.20K | -123.44K | -137.17K | -184.42K |
Operating Income Ratio | -5,137.06% | -12,142.65% | -141,482.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 1.79M | 6.22M | -3.86M | 2.13M | -2.22M | 820.86K | 1.70M | -4.70M | -107.31K |
Income Before Tax | -18.94M | -9.91M | -16.65M | -7.89M | -10.34M | 705.67K | 1.58M | -4.83M | -291.73K |
Income Before Tax Ratio | -4,694.58% | -7,461.33% | -146,802.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 2.00 | -6.32M | 110.31K | 117.05K | 155.97K | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -18.94M | -3.59M | -16.76M | -8.00M | -10.50M | 705.67K | 1.58M | -4.83M | -291.73K |
Net Income Ratio | -4,694.58% | -2,700.97% | -147,774.66% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.29 | -0.06 | -0.38 | -0.29 | -0.82 | 0.05 | 0.12 | -0.36 | -0.02 |
EPS Diluted | -0.29 | -0.06 | -0.38 | -0.29 | -0.82 | 0.05 | 0.12 | -0.36 | -0.02 |
Weighted Avg Shares Out | 64.67M | 60.62M | 44.11M | 27.22M | 12.82M | 13.30M | 13.30M | 13.30M | 13.30M |
Weighted Avg Shares Out (Dil) | 64.67M | 60.62M | 44.11M | 27.22M | 12.82M | 13.30M | 13.30M | 13.30M | 13.30M |
Perimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results and Provide Corporate Update
Perimeter Medical Imaging AI, Inc. (PYNKF) CEO Jeremy Sobotta on Q2 2022 Results - Earnings Call Transcript
Perimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss Second Quarter 2022 Financial Results and Provide Corporate Update
Perimeter Medical Imaging AI to Present at ROTH Canada Showcase Day
Perimeter Medical Imaging AI to Host Conference Call and Webcast to Discuss Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update
Perimeter Medical Imaging AI At Procurement Stage In The Sales Cycle
Perimeter Medical Imaging AI: Preventing Repeat Surgeries For Breast Cancer Patients
Perimeter Medical Imaging AI Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Perimeter Medical Imaging AI, Inc., Real-Time Imaging Tools for Surgeons, CEO Clip Video
Perimeter Medical Imaging AI Reports First Quarter 2021 Financial Results and Provides Corporate Update
Source: https://incomestatements.info
Category: Stock Reports